EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Kinetic and Structural Characterization of Trypanosoma cruzi Hypoxanthine–Guanine–Xanthine Phosphoribosyltransferases and Repurposing of Transition-State Analogue Inhibitors

Kayla Glockzin iD, Kathleen M Meneely iD, Ryan Hughes, Sean W Maatouk iD, Grace E Piña iD, Kajitha Suthagar, Keith Clinch, Joshua N Buckler iD, Audrey L Lamb iD, Peter C Tyler iD, Thomas D Meek, Ardala Katzfuss iD

Biochemistry · 2023

DOI: 10.1021/acs.biochem.3c00116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemistry, 2023. Verfasst von Kayla Glockzin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Boulevard, College Station, Texas 77843-2128, United States. Hauptthemen laut MEDLINE: Trypanosoma cruzi. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, Division of Chemistry, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over 70 million people are currently at risk of developing Chagas Disease (CD) infection, with more than 8 million people already infected worldwide. Current treatments are limited and innovative therapies are required. Trypanosoma cruzi, the etiological agent of CD, is a purine auxotroph that relies on phosphoribosyltransferases to salvage purine bases from their hosts for the formation of purine nucleoside monophosphates. Hypoxanthine-guanine-xanthine phosphoribosyltransferases (HGXPRTs) catalyze the salvage of 6-oxopurines and are promising targets for the treatment of CD. HGXPRTs catalyze the formation of inosine, guanosine, and xanthosine monophosphates from 5-phospho-d-ribose 1-pyrophosphate and the nucleobases hypoxanthine, guanine, and xanthine, respectively. T. cruzi possesses four HG(X)PRT isoforms. We previously reported the kinetic characterization and inhibition of two isoforms, TcHGPRTs, demonstrating their catalytic equivalence. Here, we characterize the two remaining isoforms, revealing nearly identical HGXPRT activities in vitro and identifying for the first time T. cruzi enzymes with XPRT activity, clarifying their previous annotation. TcHGXPRT follows an ordered kinetic mechanism with a postchemistry event as the rate-limiting step(s) of catalysis. Its crystallographic structures reveal implications for catalysis and substrate specificity. A set of transition-state analogue inhibitors (TSAIs) initially developed to target the malarial orthologue were re-evaluated, with the most potent compound binding to TcHGXPRT with nanomolar affinity, validating the repurposing of TSAIs to expedite the discovery of lead compounds against orthologous enzymes. We identified mechanistic and structural features that can be exploited in the optimization of inhibitors effective against TcHGPRT and TcHGXPRT concomitantly, which is an important feature when targeting essential enzymes with overlapping activities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trypanosoma cruziHumansPentosyltransferasesPurinesGuanine

Substanzen

hypoxanthine-guanine-xanthine phosphoribosyltransferasePentosyltransferasesPurinesGuanine

Autor:innen und Institutionen

  • Department of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Boulevard, College Station, Texas 77843-2128, United States.
  • Department of Chemistry, University of Texas at San Antonio, One UTSA Circle, San Antonio, Texas 78249, United States.
  • Ferrier Research Institute, Victoria University of Wellington, Gracefield Research Centre, 69 Gracefield Road, Gracefield, Lower Hutt 5010, New Zealand.

ORCID-Profile: Kayla Glockzin, Kathleen M Meneely, Sean W Maatouk, Grace E Piña, Joshua N Buckler, Audrey L Lamb, Peter C Tyler, Ardala Katzfuss

Förderung

  • NIAID NIH HHS
  • Division of Chemistry
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Glockzin, K., Meneely, K. M., Hughes, R., Maatouk, S. W., Piña, G. E., Suthagar, K., Clinch, K., Buckler, J. N., Lamb, A. L., Tyler, P. C., Meek, T. D., & Katzfuss, A. (2023). Kinetic and Structural Characterization of Trypanosoma cruzi Hypoxanthine–Guanine–Xanthine Phosphoribosyltransferases and Repurposing of Transition-State Analogue Inhibitors. Biochemistry. https://doi.org/10.1021/acs.biochem.3c00116

Vancouver

Glockzin K, Meneely KM, Hughes R, Maatouk SW, Piña GE, Suthagar K, et al. Kinetic and Structural Characterization of Trypanosoma cruzi Hypoxanthine–Guanine–Xanthine Phosphoribosyltransferases and Repurposing of Transition-State Analogue Inhibitors. Biochemistry. 2023. doi:10.1021/acs.biochem.3c00116

BibTeX
@article{Glockzin2023,
  author = {Glockzin, Kayla and Meneely, Kathleen M and Hughes, Ryan and Maatouk, Sean W and Piña, Grace E and Suthagar, Kajitha and Clinch, Keith and Buckler, Joshua N and Lamb, Audrey L and Tyler, Peter C and Meek, Thomas D and Katzfuss, Ardala},
  title = {Kinetic and Structural Characterization of Trypanosoma cruzi Hypoxanthine–Guanine–Xanthine Phosphoribosyltransferases and Repurposing of Transition-State Analogue Inhibitors},
  journal = {Biochemistry},
  year = {2023},
  doi = {10.1021/acs.biochem.3c00116}
}
Kostenlos starten →